+ NEU.For FA. neuren pharmaceut is a BIo company developing Therapies for brain injury, Neurological diseases, and cancer. Has a number of trails running, results soon due. Largely funded by US army and Medical research council. Started a run Friday after awarded Rett Syndrome trial grant, which is one of it's main plays. Buy side at top stacked well and expected to continue to run. Has plenty of cash with around $10mil as at last quarter. Perhaps others can give a TA perspective, but FA looking healthy. Held.
+ ABU. Gold resources company with strong cash position and suspected positive flow of further drilling results to continue this quarter. Have been watching fundamentals build for a while and missed buy point in high 3c range. Started run Friday. Scoping study for their Old Pirate project completed in May that highlights $200m+ positive cash flow once undertaken. High grades of gold in scale. Other 5 key projects all showing high potential and further updates with reporting coming across quarter. Great management team proven track record. I am waiting for retrace Monday perhaps back to around 4c then "in like Flynn"..... Not currently held.
